Sham Normobaric Hyperoxia

DRUG2 trials

Sponsors

Capital Medical University, Weifang Medical University

Conditions

Endovascular TreatmentNeuroprotectionNormobaric HyperoxiaStroke, Acute

Phase 2

Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

CompletedNCT04681651

Capital Medical UniversityNeuroprotection, Stroke, Acute

Start: 2021-04-22End: 2023-05-05Updated: 2023-07-06

Phase 3

Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND)

Not yet recruitingNCT07717216

Weifang Medical UniversityEndovascular Treatment, Neuroprotection, Normobaric Hyperoxia +1

Start: 2026-09-01End: 2029-09-01Target: 314Updated: 2026-07-21

Related Papers

Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trial.

2025-02-0111 citations